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Abstract

Plasmids in agriculturally-impacted bodies of water may play a significant role in
the dissemination of antibiotic resistance. Previously, Erika Gehr, as part of her M.S.
thesis work in our laboratory, captured environmental plasmids without cultivation of
host bacteria from stream sediment into Escherichia coli. Individual plasmids were
capable of conferring resistance to a surprising array of antibiotics including
aminoglycosides and extended-spectrum β-lactams. In this study, we developed a method
to sequence multi-drug resistance plasmids using both Oxford Nanopore MinION and Ion
Torrent Personal Genome Machine sequencers. Plasmid pEG1-1 was sequenced on both
platforms and a hybrid assembly utilizing data from both sequencing platforms generated
a single 73,320 bp contig that was annotated using automated and manual techniques.
Analysis of the genome revealed pEG1-1 to be an IncP-1β plasmid with two mobile
genetic elements – a a tn21-related transposon and an in104 complex integron – both of
which carry multiple antibiotic resistance genes. These findings suggest that plasmids in
stream sediment are prone to the incorporation of mobile genetic elements that introduce
a broad range of antibiotic resistance genes into their genome. This could cause serious
risk to human health since IncP-1β plasmids are capable of transferring into nearly all
Gram-negative bacteria, including fecal pathogens that get introduced to stream sediment.

vi
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Introduction
Antibiotics and the Threat of Resistance. Antibiotics have saved millions of
lives around the world and have been recognized as one of the most successful forms of
chemotherapy in the history of medicine (Aminov, 2010). Antibiotics have cured and
prevented otherwise fatal diseases, enabled major advances in surgery, and even helped
to extend the life expectancy of humans (Gould & Bal, 2013; Ventola, 2015). Morbidity
and mortality caused by infectious diseases have drastically decreased in developing
countries due to antibiotic use (World Health Organization (WHO), 2014). In the 1960’s,
the use of antibiotics had such a drastic effect on public health that the Surgeon General
of the United States of America, William Stewart, proclaimed “The time has come to
close the book on infectious diseases. We have basically wiped out infection in the
United States” (Upshur, 2008). Unfortunately, nearly fifty years later, the book on
infectious diseases is wide open and a new chapter is unfolding.
Antibiotic resistance (AR) has been deemed one of our most serious health threats
(Centers for Disease Control [CDC], 2013). AR infections have been reported around the
globe and the number of instances continues to rise (Ventola, 2015). In the United States
alone, serious infections attributed to a pathogen resistant to at least one antibiotic have
reached rates of more than 2 million patients a year, with at least 23,000 dying as a result
(CDC, 2013). For example, methicillin-resistant Staphylococcus aureus is now one of
America’s most lethal diseases, surpassing fatality rates of HIV/AIDS, Parkinson’s
disease, emphysema, and homicide combined (Gross, 2013). Other organisms of
particular concern due to their recently acquired antibiotic resistance or increasing
pathogenicity include Mycobacterium tuberculosis; Streptococcus pneumoniae;
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Acinetobacter spp., Stenotrophomonas maltophilia, and Pseueomonas aeruginosa (all
intrinsically resistant to many antibiotics); Salmonella enterica and pathogenic E. coli;
and Extended-Spectrum Beta-Lactamase- (ESBL) and Carbapenemase-Resistant
Enterobacteriaceae (CRE).
Efforts to combat the growing problem of antibiotic resistance are being carried
out by national and international bodies around the world (WHO, 2014). In March of
2015, the White House released the “National Action Plan for Combating AntibioticResistant Bacteria” (The White House Office of the Press Secretary, 2015). In this
document, the U.S. government declared that research and surveillance of antibiotic
research are critical factors that will lead to reduced instances of the deadliest multi-drug
resistant organisms, including CRE and MRSA. They assert that, with a better
understanding of how and why resistance spreads, policies can be made to curb its
acceleration (The White House Office of the Press Secretary, 2015).
The predominant factor contributing to the increasing prevalence of antibiotic
resistance is thought to be the overuse of antibiotics, especially in agriculture (Zur
Wiesch et al., 2011). In 2013, the Food and Drug Administration reported that 74% of the
medically important antimicrobials sold were administered in animal feed—the majority
of which is used for non-therapeutic growth promotion (United States Food and Drug
Administration, 2012). The use of antibiotics as an additive to food has been shown to
increase feeding efficiency, thereby promoting growth rate by up to 5% in dairy cattle,
sheep and goats, relative to animals not treated with antibiotics (Khachtourians, 1998).
However, these gains come with profound consequences. Agricultural use of antibiotics
has been strongly linked to resistance (Smith et al., 2002). Antibiotic-resistant bacteria
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have been isolated on animals treated with antibiotics (Aarestrup, 1999), food products
(Chadwick et al., 1996), and even environments treated with animal waste (Chee-Sanford
et al., 2001; Brooks, 2005).
Work from our lab showed that the use of prophylactic antibiotics in turkeys
increased the presence of antibiotic-resistant bacteria in litter (Brooks, 2005). Brooks
quantified culturable bacteria resistant to tetracycline from the litter of tetracyclinetreated turkeys and turkeys not treated with tetracycline. His results showed that
tetracycline-resistant bacteria were present in significantly greater numbers in litter from
turkeys that received tetracycline treatment (Brooks, 2005).
These data are especially concerning since contamination of agricultural soils can
reach water systems through runoff. In Virginia, 68% of the state’s rivers that are
designated as Impaired by the Virginia Department of Environmental Quality (DEQ) are
degraded by fecal bacteria. In the Potomac-Shenandoah River basin, that number jumps
to 80% (DEQ, 2014).
Escherichia coli is used as an indicator of fecal contamination because it is not
considered to persist in freshwater for more than a few days (Gordon et al., 2002). While
this holds true for E. coli in the water column, this may not be the case in stream
sediment. A 1979 analysis of E. coli populations in sediment compared to the water
column in streams in southwestern Idaho indicated that the E. coli concentration was 2 to
760 times greater in the sediment when compared to that in the water (Stephenson &
Rychert, 1982). More recently, a mesocosm experiment was set up by inoculating water
and sediment with fecal contaminants. By enumerating E. coli in the sediment and
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freshwater over time, the authors showed that the decay rate of E. coli in sediment is
about 70% lower than E. coli in water (Anderson et al., 2005). Work in our lab compared
the E. coli colony forming units obtained from stream water versus stream sediment
(Gehr, 2013). Over a three month span, Gehr demonstrated that stream sediment had a
consistently higher number of E. coli colony forming units than stream water and that
specific strains appeared to persist over time in the sediment only (Gehr, 2013).
Persistence in stream sediment may allow fecal bacteria such as E. coli to interact
with the large and diverse native microbial population (Nealson, 1997). Through
horizontal gene transfer these fecal pathogens could introduce and/or gain access to the
pool of genes present in bacterial populations native to stream sediment.
Horizontal Gene Transfer and Antibiotic Resistance. Horizontal gene transfer
is the exchange of DNA amongst mature bacteria through viral infection (transduction),
direct uptake of free DNA (transformation) or the transfer of plasmids through direct cellto-cell contact (transconjugation). Whole-genome investigations of bacterial species have
shown that significant portions of nearly all bacterial genomes contain foreign DNA that
has been introduced via horizontal gene transfer (Ochman et al., 2000; Pallen & Wren,
2007). For example, the sequencing of multiple, diverse E. coli genomes has revealed a
conserved, “core genome” interspersed with multiple regions of high variability. These
variable regions are strain-specific and often include mobile elements that code for
increased virulence and pathogenicity (Dobrindt et al., 2010). In Salmonella, for example,
sseI and sodCI genes have been found on prophages—genomes of bacteriophages that
have been inserted into bacterial genomes (Figueroa-Bossi, 2001).
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The horizontal exchange of genetic material offers a mechanism for some bacteria
to rapidly adapt to changing environments (Claverys, 2000). The mass distribution of
antibiotics in both medicine and agriculture has added a unique selective pressure to the
environment. In response, horizontal gene transfer has aided in the emergence of
resistance (Davies & Davies, 2010).
The preeminent means of antibiotic resistance transmission is through plasmid
conjugation (Davies & Davies, 2010). Plasmids are mobile molecules of circularized
DNA that can carry genes involved in virulence, pathogenicity and antibiotic resistance
(Kelly et al., 2009, Revilla et al., 2008). Plasmid-mediated resistance genes have been
associated with most clinical antibiotics, including those of “last resort”, drugs reserved
for infections exhibiting resistance to all other antibiotics. (Bennet, 2008).
A major contributing factor to the dissemination of plasmid-mediated resistance is
the capability of certain plasmids to conjugate into a broad-range of bacterial hosts. For
example, plasmids from the incompatibility groups IncP can transfer and maintain
themselves in nearly all Gram-negative bacteria (Dröge et al., 2000). Incompatibility
(Inc) groups are based on replication and partitioning systems; plasmids belonging to the
same Inc group cannot coexist in a single cell because of competing replication and
partitioning genes (Shintani et al., 2010a). These genes are also contributing factors to a
plasmid’s capacity to successfully conjugate into certain hosts.
The replication and partitioning system shared by all IncP-1 plasmids allow for
successful conjugation in a broad range of hosts (Shintani et al., 2010b). IncP-1 plasmids
have been found in virtually all Gram-negative bacteria, including E. coli and
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Pseudomonas spp., and in pathogens and commensals from a wide variety of sources,
such as hospital and other clinical and veterinary settings, agriculturally-impacted soils
and wastewater treatment plants (Bahl, 2009; Norberg et al., 2011). Along with their
broad host range, IncP-1 plasmids can carry genes encoding antibiotic resistance
(Popowska & Kraqczyk-Balska, 2013). These two factors make IncP-1 plasmids of
particular interest to molecular and environmental biologists working to understand the
underlying mechanisms driving the evolution and spread of antibiotic resistance.
IncP-1β plasmids, a subgroup within the incompatibility group IncP-1, have been
found to confer multi-drug resistance in a wide range of bacterial hosts (Lee et al., 2003).
The Tra1 and Tra2 regions of the IncP-1β backbone—gene sequences that mediate
conjugative transfer—are separated by regions of clustered restriction sites, hotspots for
the integration of mobile genetic elements (Popowska & Kraqczyk-Balska, 2013).
Transposons carrying antibiotic resistance genes, such as the aminoglycoside resistance
Tn5393c transposon found on plasmid pB4 (Tauch A. et al., 2003), are commonly found
between the Tra1 and Tra 2 regions of IncP-1β plasmids.
Because it is typical to find these plasmids in agricultural sites, clinical settings
and wastewater treatment plants, IncP-1 plasmids have an opportunity to transmit
antibiotic resistance genes to human pathogens through HGT. An in vitro conjugation
assay of pB10, an IncP-1β plasmid carrying two multi-drug resistant transposons,
demonstrated that the plasmid could be transferred to the food-borne pathogens E. coli
and Salmonella spp. (Van Meervenne et al., 2012). These data demonstrate the urgency
to understand more about IncP-1 plasmids and their role in antibiotic resistance. The
analysis of IncP-1 plasmid genomes has helped to uncover the importance of mobile
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genetic elements, but the database is limited (Popowska & Kraqczyk-Balska, 2013).
Currently, only five complete sequences of IncP-1β plasmids have been published
(Popowska & Kraqczyk-Balska, 2013).
Next Generation DNA Sequencing. Modern DNA sequencing began in 1975
when the first complete sequence, that of bacteriophage phi X174, was published (Sanger
& Coulson, 1975). Sanger & Coulson sequenced the phage DNA using their ‘plus and
minus’ method of DNA sequencing. Two years later, Sanger et al. refined the ‘plus and
minus’ method, creating a more efficient means of sequencing, termed the chain
termination method (Sanger et al., 1977). Sanger sequencing has since been utilized to
sequence a broad range of genomes, but the chemistry of Sanger sequencing made
increasing throughput (i.e. the amount of DNA being sequenced per run) expensive. In
2004, these constraints were lifted with the introduction of massively parallel sequencing
technology, or next-generation sequencing (NGS) (Morey et al., 2013).
What distinguishes NGS from Sanger sequencing is the capability of NGS
platforms to produce read information on multiple samples of DNA in a single reaction
(Morey et al., 2013). This enabled massive amounts of data to be produced in a single
sequencing run, bringing costs to unprecedented lows. In 2004, it cost nearly $1,000 to
sequence 106 bp. In 2015, thanks to improving technologies of NGS platforms,
sequencing 106 bp cost less than a dime (National Institutes of Health, 2016).
The massive data output of these second-generation sequencers is due to
chemistries that produce sequence data through cyclic parallel readings of clonally
amplified, spatially separated amplicons (Mardis, 2008). While the details differ between
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platforms, second-generation sequencers operate under the same, basic workflow
principles (Morey et al., 2013). First, sample DNA is clonally amplified and denatured
into single-stranded fragments. Examples of clonal amplification techniques are emulsion
PCR and bridged amplification. Clonally amplified products are then spatially separated,
usually across microchips or flowcells. Next, polymerization of the amplified product’s
complementary strand is initiated, releasing specific byproducts, e.g. hydrogen ion or
pyrophosphate, upon the incorporation of a complimentary nucleotide. Since the sample
DNA has been clonally amplified, polymerization byproducts are released in sufficient
quantities to be detected. On NGS platforms, multiple samples of DNA can be sequenced
in a single reaction since each reaction is occurring in a distinct spatial location, (Morey
et al., 2013). With this innovative sequence chemistry, data could be produced more
quickly and at a significantly lower cost than Sanger sequencing (NIH, 2016).
However, this technology does have its limitations. Clonal amplification of
sample DNA can introduce amplification biases that can drastically decrease the quality
of sequence data (Acinas et al., 2005). Also, the chemistries of NGS limit the read
lengths produced to <500 bp (Morey et al., 2013). Short read lengths can make
assemblies of large genomes difficult and sometimes impossible (Whiteford et al., 2005).
New sequencing technology has been introduced that no longer relies on clonal
amplification and can produce reads upwards of tens of thousands of base pairs in length.
This new wave of technology has established a third-generation of NGS platforms
(Morey et al., 2013).
The two third-generation platforms commercially available are the Pacific
Biosciences’ Single-Molecule Real Time (SMRT) Sequencer and Oxford Nanopore
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Technologies’ MinION. While these platforms employ drastically different chemistries,
both sequence DNA through single-molecule processing (Heather & Chain, 2016).
Rather than clonally amplifying sample DNA, third-generation platforms generate
sequencing reads from the original, single molecule of DNA. Third-generation
sequencers also apply partial separation of samples which, like second-generation
platforms, allows for massively parallel reactions to occur. Unlike second-generation
platforms, the problem of amplification bias is not an issue for third generation
sequencers since there is typically no amplification step. Also common amongst thirdgeneration sequencers is the production of long sequencing reads. Long reads are
particularly useful in assembling regions of a genome that contain large repeats (Heather
& Chain, 2016).
The major drawback of third-generation platforms is their accuracy. Secondgeneration machines have average error rates lower than 1%, but an evaluation of the
SMRT Sequencer system showed error rates as high as 15% (Carnerio et al., 2013) and
an assessment of the MinION reported an error rate of around 8% (Jain et al., 2015).
Rather than rely on the low accuracy data generated on third-generation platforms, or the
short-read data generated on second-generation platforms, some researchers perform
hybrid assemblies that utilize data obtained from both second- and third-generation
sequencers (Koren et al., 2012).
DNA Sequencing of Multi-Drug Resistance Plasmids. Previous work in our lab
revealed the presence of multi-drug resistance plasmids in sediment of agriculturallyimpacted streams (Gehr, 2013; Herrick et al., 2014). Gehr used an exogenous capture
method to capture (or conjugate) plasmids from samples of stream sediment of Shull
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Run, a tributary of Mountain Run and Smith Creek in Rockingham County, Virginia
(Gehr, 2013) direcly into E. coli cells without culturing the plasmid donor cells. She then
used a modified Stokes susceptibility assay to determine the antibiotic resistance profile
of the captured tetR plasmids (Gehr, 2013). Gehr demonstrated that some of these tetR
plasmids conferred decreased susceptibility to a surprising array of clinical antibiotics,
including cefepime, a fourth generation cephalosporin, suggesting that a significant
reservoir of antibiotic resistance genes may be present in stream sediment impacted by
agricultural runoff (Gehr, 2013).
In this study, we sequenced a tetR plasmid captured by Erika Gehr, pEG1-1, and
demonstrated how genome analysis of multi-drug resistance plasmids allows a better
understanding of the reservoir of ARG present in stream sediment. We have developed
methods to isolate plasmid DNA, sequence it on two NGS platforms—the Ion Torrent
PGM and Oxford Nanopore Technologies’ MinION— combine the data for hybrid
assembly, and annotate the genome. Using these methods, we were able to classify
pEG1-1 as an IncP-1β plasmid and uncovered the presence of two complex mobile
genetic elements: a unique tn21-related transposon and an in104 complex integron, each
of which carries multiple antibiotic resistance genes.
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Methods
Plasmid pEG1-1. Plasmid pEG1-1 is a stream sediment plasmid captured and
characterized by Erika Gehr as part of her M.S. thesis research (originally designated
“p1-1” in her study) (Gehr, 2013). It conferred decreased susceptibility to tetracycline,
tobramycin, kanamycin, ticarcilin, piperacillin, piperacillin-tazobactam, and cefipime
(Gehr, 2013). It was exogenously captured from a stream sediment sample from Shull
Run, a tributary of Mountain Run and Smith Creek in Rockingham County, Virginia. It
was kept frozen at at -20°C in 100 µl sterile ddH2O. The antibiotic resistance profile of
pEG1-1 was determined by Gehr (and verified in this study) using a modified Stokes disc
diffusion antibiotic susceptibility assay (Gehr, 2013; Herrick, et al., 2014). Minimum
inhibitory concentrations (MICs) of pEG1-1 were determined using Sensititre Gram
Negative Xtra Plate Format (Trek Diagnostics Inc., Cleveland OH) according to the
manufacturer's instructions and NCCLS standards.
Plasmid isolation and purification. A plasmid preparation procedure previously
developed in our laboratory for the isolation of large, native, single-copy plasmids (Gehr,
2013) was scaled up in order to isolate and purify large quantities of pEG1-1.
Transconjugant or transformant cells were grown in 30 ml of trypticase soy broth with
shaking at 37º C overnight. Cells were harvested by centrifugation at 10,000 g for 5 min
and resuspended in 2 ml of resuspension buffer (10 mM EDTA; 50 mM dextrose; 10 mM
Tris-Cl, pH 8.0). Four milliliters of 0.2 M NaOH/1% SDS were added and the mixture
kept at room temperature for 5 min to lyse the cells. Three milliliters of ammonium
acetate and 3 ml of chloroform were added and the lysate immediately centrifuged at
16,000 x g for 10 min. The supernatant containing plasmid DNA was added to 4 ml of
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30% polyethylene glycol 8000/1.5 M NaCl and chilled on ice for 15 min. Plasmid DNA
was pelleted by centrifugation at 16,000 g and resuspended in 1 ml of sterile ddH2O. This
solution was kept at 4º C for at least 24 hours to allow plasmid DNA to fully resuspend
and then the DNA was stored at -20° C in sterile ddH2O.
The presence of plasmid DNA was confirmed by agarose gel electrophoresis. A
0.7% agarose gel was cast by boiling 0.35 g of agarose in 50 mL of bionic buffer (SigmaAldrich, St. Louis, MO) and adding 2.5 µL of 10,000X GelRed Nucleic Acid Gel Stain
(Biotium, Hayward, CA). Ten microliters of plasmid DNA mixed with 2 µl of 6X loading
dye was run on the gel at 3.5V/cm for 90 min. Gel photographs were taken with a Kodak
DC 290 digital camera (Kodak, New Haven, CT) and analyzed using Kodak 1D
Scientific Imaging System v.3.5.4.
To remove chromosomal DNA, plasmid DNA was treated with Plasmid-Safe™
ATP-Dependent DNase (Epicentre Technologies, Madison, WI). Eight-hundred and forty
microliters of the plasmid DNA were added to an Eppendorf® RNA/DNA LoBind
microcentrifuge tube (Sigma-Aldrich, St. Louis, MO) and mixed with 3 µl of PlasmidSafe DNase, 100 µl of Plasmid-Safe 10X Reaction Buffer, 40 µl of 25 mM ATP solution
and 6.25 µl of RNase A (Qiagen, Venlo, Netherlands). The mixture was incubated at
37° C for 30 min and the enzymes were inactivated by incubation at 70° C for 30 min.
Plasmid DNA was purified in 200 µL aliquots using a 1X concentration of Ampure XP
Beads (Beckman Coutler, Brea, CA) according to manufacturer’s protocol and eluted
using 30 µl of sterile ddH2O.
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Electroporation. Plasmid DNA was precipitated with ethanol to remove residual
salt and electroporated into the electrocompetent tetracycline susceptible (tetS) E.coli
strain EC100 (Epicenter Technologies, Madison, WI using 1mm glass cuvettes) using a
Bio-Rad GenePulser Xcell electroporator according to the manufacturer’s instructions
(Bio-Rad, Hercules, CA). EC100 was maintained and prepared for electroporation
according to protocol 6.1.1 of the Bio-Rad® Gene pulser instruction manual.
Transformed cells were plated on tetracycline- (25 µg ml-1) amended TSA plates
and incubated for 48 hours at 37°C. Colony presence was considered indicative of
successful transformation. Electroporated transformants were used for antibiotic
resistance profiling. Plasmids from the tetR transformant isolates were isolated using the
plasmid preparation protocol outlined above.
Ion Torrent Personal Genome Machine Sequencing. A 400 bp PGM library
was constructed for plasmid pEG1-1 using the Ion Xpress™ Plus Fragment Library Kit
(Thermo Fisher, Waltham, MA). DNA was fragmented using the Ion Plus Fragment
Library Kit & Ion Shear™ Plus Reagents Kit. Ligation of PGM adapters, nick-repair, size
selection and purification of the library was performed according to the manufacturer’s
instructions. Final library concentration was determined using the Qubit® dsDNA HS
Assay Kit (Thermo Fisher, Waltham, MA). The prepared library was diluted to 100 pM
with TE (10 mM Tris pH 8.0, 0.1 mM EDTA) and used to create a PGM template using
the PGM™ Hi-Q™ OT2 Kit on the Ion OneTouch machine, according to manufacturer’s
instructions.
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The template was prepared for sequencing using the Ion PGM™ Hi-Q™
Sequencing Kit (Thermo Fisher, Waltham, MA) and loaded onto an Ion 318™ Chip.
Using the Torrent Suite™ Software, a sequencing run was executed using the “Generic
Sequencing” template and the parameters listed in Table 1.
Table 1. Ion Torrent PGM run-analysis options.

PGM Analysis Summary
Run Flows:
Flow Order:
Library Key:
3' Adapter
Chip Type:
Chip Data:
Barcode Set:
Bead Loading Quality
Threshold:
Plugins
a

850
TACGTACGTCTGAGCATCGATCGATGTACAGC
TCAG
Ion P1B
318C
Single
IonXpress
30%
FileExportera

Converts sequence data to FastQ file format.

Oxford Nanopore Technologies’ MinION Sequencing. Plasmid DNA was
fragmented using a partial restriction digest. Five-hundred-thirty seven microliters of
purified plasmid DNA were mixed with 60 µL of NEBuffer 1.1 and 0.6 µL of 5,000
U/mL Sau3A1 enzyme (New England BioLabs, Ipswich, MA) and incubated at room
temperature for one minute. The enzyme was immediately inactivated by incubating the
solution at 70° C for 30 min.
The fragmented DNA was purified using a 1X concentration of Ampure XP
Beads (Beckman Coutler, Brea, CA) according to the manufacturer’s protocol and eluted
into 30 µl of sterile ddH2O. Successful fragmentation of plasmid DNA was confirmed by
agarose gel electrophoresis (Figure 2) as described above. Fragmented DNA was
quantified using the Qubit® dsDNA HS Assay Kit (Thermo Fisher, Waltham, MA). One
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microgram of fragmented DNA was used to prepare a MinION sequencing library
according to the manufacturer’s protocol (Sequencing kit SQK-005, Oxford Nanopore,
Oxford UK).
A sequencing run was created on MinKnow using the built-in python script
“48Hr_Sequencing_Run_SQK_MAP005.py”. MinION sequencing solution was prepared
by mixing 75 µL of 2x Running Buffer, 65 µL ddH2O, 4 µL Fuel Mix and 6 µL of the
prepared MinION sequencing library, and the solution was loaded into a R7.3 flow cell
(Oxford Nanopore, Oxford UK). The preparation and loading of sequencing solution was
repeated four times every six hours allowing for a total 24 hour sequencing run. MinION
raw sequence data was basecalled using the Oxford Nanopore Metrichor software (2D
Workflow, revision 1.9.1).
Genome Assembly and Annotation. PGM data were normalized to 100X
coverage using the BBNorm normalization tool of the BBTool package (Bushnell, 2014)
and MinION reads were error-corrected using Nanocorrect (Loman et al., 2015).
Normalized PGM reads and Nanocorrected MinION reads were input into the SPAdes
assembler V3.7 (Bankevich et al., 2012) for a hybrid assembly using k-mer lengths 43,
53, 63, and 73 as well as the pipeline option “--careful”. The reads were assembled into a
single 74,302 kb contig. Because the plasmid genome was circular, a repeated sequence
on both ends of the assembly was anticipated. To identify this region, the contig was split
in half and the two halves were aligned to one another using Mauve (Darling et al.,
2010). This revealed a 982 bp repeated sequence on both ends of the assembly that was
removed from one end. The final 73,320kb contig was first annotated using the
automated annotation software Prokka (Seemann, 2014) and then manually annotated.

16

Manual annotation consisted of first assessing each annotation made by Prokka on
the basis of % identitiy to the matched reference (plasmid pB8; <90% was removed), %
coverage of the matched reference (<90% was removed), and e-value (>10-6 was
removed). Prokka annotates genes as “hypothetical proteins” if the predicted gene cannot
be matched to a reference within the large protein databases UniProt or Pfam (Seemann,
2014). These hypothetical proteins were manually extracted and locally aligned
(BLASTp) to smaller, manually curated databases. The smaller databases used were
CARD (McArthur et al., 2013) and INTEGRALL (Soares, M. et al., 2009). Areas of the
genome >100 bp that did not receive a Prokka annotation were extracted and also aligned
to the smaller databases described above. Prior to adding a manual annotation, the
presence of a predicted protein-coding gene was verified using GLIMMER 2.1 (Delcher
et al. 1999). Global alignments of homologous regions between pEG1-1 and the
reference plasmid pB8 were also utilized to confirm annotations.
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Results
Methods Development to Prepare Plasmid DNA for Sequencing on NextGeneration Platforms. The removal of RNA and chromosomal DNA contaminants was
verified through agarose gel electrophoresis (Figure 1). Lane 1 of both gels contains the
raw product of a plasmid prep protocol. In Figure 1b, RNA was observed as fragments
<500bp and chromosomal DNA was observed as smears near the top of Lane 1. Lane 2
of both gels contains plasmid DNA after Plasmid-Safe and RNase A treatment. In both
gels, no RNA or chromosomal contaminants were observed in Lane 2.
Large quantities of DNA are necessary to sequence a plasmid on multiple NGS
platforms. The MinION sequencing protocol requires 1µg of sample DNA and the PGM
protocol requires at least 0.10µg. The average yield from the plasmid miniprep developed
in our lab was only around 0.3 µg (Figure 1). Running multiple plasmid preps one after
another is impractical and time consuming, and running multiple preps in parallel is
prone to error since many of the reactions within the protocol are time-sensitive. Instead,
we elected to scale-up the original plasmid prep protocol by a factor of 20.
The efficacy of the scaled-up protocol was verified through agarose gel
electrophoresis (Figure 1b). Lane 1 contains the raw product of the scaled-up plasmid
prep. Plasmid DNA in both a supercoiled state (band at ~20kb) and relaxed conformation
(band at >20kb) was observed. Greater quantities of RNA and chromosomal DNA
contaminants compared to the original protocol (Figure 1a) were also present, but both
contaminants were fully removed after Plasmid-Safe and RNase A treatment (Figure 1b).
Concentration and yield of the plasmid DNA were obtained by first fragmenting the
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1

A

2

1

B

2

23,130bp
23,130bp

564bp
564bp

Concentration (ng/µL) 5.529 ± 0.547
Yield (µg)
0.276 ± 0.0273

Concentration (ng/µL) 4.44 ± 0.655
Yield (µg)
4.442 ± 0.0655

Figure 1. Original and scaled-up plasmid preparation protocols. (A) Isolated pEG1-1 using
the original protocol. (B) Isolated pEG1-1 using the scaled-up protocol. Samples were run
with the following lane assignments - Lane 1: raw product from the plasmid prep, Lane 2:
plasmid after Plasmidsafe and RNase treatment. The blue and red arrows indicate plasmid
DNA in either a supercoiled or relaxed conformation, respectively. The molecular weights
indicated to the left of each gel image are based on a Lambda DNA/HindIII marker run in
each gel. The concentration of plasmid DNA was determined using the Qubit BR assay kit.
The concentration was multiplied by the final volume of the sample to determine yield. The
data shown is the average concentration and yield of 7 samples with a standard deviation
expressed as a ± value.

plasmid DNA with Sau3AI and then quantifying each sample with the Qubit dsDNA BR
Assay Kit. The average yield of the scaled-up protocol was 4.44 µg, a nearly 20-fold
increase compared to the average yield obtained from the original plasmid prep.
All NGS platforms require sample DNA to be linear in order to ligate the
appropriate oligonucleotide sequences and/or specialized adapter proteins required for
each platform’s sequencing chemistry (Morey et al., 2013). In addition, the PGM requires
shearing to an average size of 400 bp. The PGM sequencing protocol employs an
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enzymatic fragmentation method that has been optimized and commercially available for
over five years (Ion Torrent, 2014). Plasmid DNA that has been treated with PlasmidSafe and RNase can be input directly into the PGM protocol for successful sequencing.
At the time of this study, however, the MinION sequencing protocol was still in beta
testing through the MinION Access Programme and not yet optimized nor commercially
available.
The suggested method for fragmenting the DNA library to be sequenced by the
MinION was to use the Covaris G-tube. The G-tube shears DNA by using centrifugal
force to push the sample through a precisely manufactured pore. The size of the
fragments produced is dependent on the amount of centrifugal force applied.
Unfortunately, our attempts to fragment plasmid DNA with a G-tube were unsuccessful:
sequence runs utilizing the G-tube resulted in almost zero reads, suggesting that the
plasmid was not being sufficiently linearized for proper ligation of adapter proteins
during library preparation. It was hypothesized that the supercoiled state of plasmid DNA
impeded successful shearing through the G-tube. Instead, fragmentation was
accomplished through the use of partial restriction digestion with the four-base restriction
enzyme Sau3AI.
Successful fragmentation was verified via agarose gel electrophoresis (Figure 2).
Lanes 1 and 2 show the raw product of a scaled-up plasmid prep and circularized plasmid
DNA after Plasmid-Safe and RNase A treatment, respectively. Lane 3 contains
fragmented plasmid DNA after the partial restriction digest. A smear, indicating multiple
fragments, from ~20kb to ~300kb was observed.
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2

3

23,130bp

564bp

Figure 2. Plasmid DNA preparation for MinION sequencing. Lane 1: raw product from the
scaled-up plasmid prep. Lane 2: purified plasmid product after Plasmidsafe and RNase
treatment. Lane 3: fragmented plasmid DNA after partial digestion using the four-base
restriction enzyme sau3AI. Molecular weights are estimates based on a Lambda DNA/HindIII
marker run in the same gel.

Sequencing on the Ion Torrent PGM. For PGM sequencing, two1 400 bp
libraries were prepared using plasmid pEG1-1 DNA that had been isolated and purified
of RNA and chromosomal DNA contaminants using the methods described in the
previous chapter. The libraries were pooled together and clonally amplified through
emulsion PCR on Ion Sphere Particles™ (ISP), which were then loaded onto an Ion 318
Chip for sequencing on the Ion Torrent PGM. The sequence run diagnostics are presented
in Figure 3.
The ISP Load and color map are measures of Ion Sphere Particles (ISP) loaded
into the microwells of a sequencing chip (Figure 3a). The ISP Load is the percentage of
microwells loaded with an ISP and is a metric of proper library preparation and chip1Two separate PGM libraries were prepared with the assumption that each library was generated from two

different plasmids. However, after performing a Modified Stokes disk-diffusion assay (Gehr, 2013), it was
revealed that the two libraries were both generated from plasmid pEG1-1. Therefore, the PGM data from both
libraries were combined for assembly.
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loading (Ion Torrent, 2015). An ISP Load of 30% is a quality threshold set by the Torrent
Suite™ software (Ion Torrent, 2015). An ISP Load below 30% is indicative of a failed
run. The ISP Load generated during the sequence run of plasmid pEG1-1 was 57%,
exceeding the quality threshold.
The color map is a representation of ISP loading distribution and is a second
proxy for proper chip loading. The color blue indicates 0% ISP loading and red indicates
100% ISP loading in the represented area. The map is represented as a square, but the
chip has rounded edges. For this reason, the top left and bottom right corners are
completely blue. According to the manufacturer’s protocol, an even distribution of ISP is
ideal (Ion Torrent, 2015). The color map generated during the sequence run of plasmid
pEG1-1 was a marbled mix of yellow and red, but contained a large region of blue on the
bottom of the chip (Fig 3a). The chip-loading procedure was complex and dependent on a
number of steps (Ion Torrent, 2014). The researcher conducting the chip-loading
procedure had little experience at the time with such a protocol and it was assumed that
the large region of low ISP density was a product of poor chip-loading technique.
The PGM produced 4.180 million reads with an average read-length of 204 bp
(Figure 3b). Two 400 bp libraries were prepared; thus an average read-length of 400 bp
was expected. However, similar to the chip-loading protocol, the Ion Xpress™ Plus
Fragment Library protocol consists of many procedures new to the researcher conducting
the library preparation. Operator error, in addition to the uneven ISP density, may have
led to improper size selection of DNA fragments.
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Q-score, or Phred quality score, is the standard metric of read quality and has an
inverse, logarithmic relation to the probability of error of a base call (Ewing, 1998). For
example, Q = 10 indicates a 1 in 10 probability of error, Q = 20 indicates a 1 in 100
probability of error, Q = 30 indicates a 1 in 1,000 probability of error and so on. A plot of
the range of Q-scores across all bases at each position was generated on FastQC
(Andrews, 2010) (Figure 3c). The average !-score of base calls in positions <300bp bp
A

B

A
ISP Load: 57%

20,000

Count

Mean read-length: 204bp
Total reads: 4.180M bp
5,000

100

200

300

Read Length (bp)

C

400

500

40

Q-score

30

20

10

0
0

4

6

9

25-29

45-49

80-89

300-349

450-499

Position in Read (bp)

Figure 3. Ion Torrent PGM sequence. (A) Map of Ion Sphere Particles (ISP) loaded onto the
Ion 318™ Chip for sequencing of plasmid pEG1-1. Color indicates the percentage of wells
occupied by an ISP in a given area. The ISP Load is the total percentage of wells loaded with
an ISP. (B) Read-length histogram of sequence data produced. (C) FastQC-generated plot
(Andrews, 2010) of the range of quality scores across all bases at each position. For each
position a BoxWhisker plot is drawn. The central red line is the median value, the yellow box
represents the inter-quartile range (25-75%), the upper and lower whiskers represent the 10%
and 90% points, and the blue line represents the mean quality
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was greater than Q = 20 (i.e. >99% base call accuracy). Thus, despite an average readlength shorter than expected and regions of low ISP density, high quality reads were
obtained from the PGM sequence run.
Sequencing on Oxford Nanopore Technologies’ MinION. Plasmid pEG1-1
was isolated, purified of RNA and chromosomal DNA contaminants and fragmented via
partial digest using the methods described above. Fragmented pEG1-1 DNA was used to
generate two2 MinION sequence libraries. As part of the library preparation protocol, a
hairpin-adapter was ligated to the end of DNA fragments (Sequencing kit SQK-005,
Oxford Nanopore, Oxford UK). The hairpin-adapter allows for both the template and
complement strand of DNA to traverse a nanopore during a sequencing run. Reads
produced by combining data from both strands are known as 2D reads and have a higher
accuracy compared to reads produced from just the template strand, termed 1D reads
(Loman et al., 2015). For this study, only the higher quality, 2D reads.
Two sequence runs (Run 1 and 2) were conducted for each library separately.
Both runs were performed using R7.3 flow cells (Oxford Nanopore, Oxford UK). After
sequencing, the raw data (i.e. current disruptions over time) of both runs were base called
– i.e. converted to sequence reads – through the Oxford Nanopore program Metrichor
(2D Workflow, revision 1.9.1), and separated into 1D and 2D reads. Sequence Run 1 and
2 diagnostics a=are based on the data of 2D reads (Figure 4).
The previous section showed that plasmid DNA can be fragmented to 20 kb using
the methods we have developed. However, at the time of both sequence runs, the use of
2Two sequence runs on plasmid pEG1-1 were conducted with the same assumptions as noted previously with

the PGM sequencing (i.e. it was falsely assumed that the two libraries were generated from two different
plasmids). As with the PGM data, the data generated fromoth MinION runs were combined for the assembly.
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Figure 4. Oxford Nanopore Technologies’ MinION sequence diagnostics. (A, B) Read-length
histogram of sequence data produced in Run 1 and Run 2, respectively. (C, D) ) FastQCgenerated plot (Andrews, 2010) of the range of quality scores across all bases at each position
in Run 1 and Run 2, respectively. For each position a Box Whisker plot is shown. The central
red line is the median value, the blue line represents the mean, the yellow box represents the
inter-quartile range (25-75%), and the upper and lower whiskers represent the 10% and 90%
points.
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restriction digestion had not been optimized to generate 20 kb fragments. Fragmentation
of plasmid DNA used in Run 1 and Run 2 were visualized on an agarose gel prior to
preparing the sequence libraries. The gels revealed fragmented plasmid DNA ranging
from 7 kb to <500 bp for the DNA used in Run 1 and from 10 kb to <500 bp for the DNA
used in run 2. This was consistent with the distribution of read-lengths produced during
each run (Fig 4a,b). Run 1 generated 5,387 2D reads with an average read-length of 1,612
bp and the largest read produced in Run 1 was 22,229 bp. Run 2 generated 2,103 2D
reads with an average read-length of 4,019 bp and the largest read produced in Run 2 was
36,364 bp. The average read-lengths from Run 1 and 2 exceed the average PGM readlength by a factor of 10 and 20, respectively.
As with the PGM data, a range of Q-scores across all bases at each position was
generated on FastQC (Andrews, 2010) for both Run 1 and 2 (Fig 4c, d). Both plots show
that the Q-score of all base calls averages are ~10, (i.e. ~90% base-call accuracy).
Hybrid Assembly. Before combining PGM and MinION data for hybrid
assembly, both datasets were adjusted to ensure optimal input-data quality (Figure 5) The
PGM reads were normalized to 100x coverage using the program bbnorm (Bushnell,
2014). This was done to adjust for the uneven coverage bias associated with the platform
(Quail et al. 2012). An assembly without normalization was attempted, but PGM depthof-coverage, or the number of times a specific base was sequenced, ranged from >2,000X
to 50X. An uneven depth-of-converge as drastic as this hinders the assembly process and
can introduce error into constructed contigs (Chen et al., 2013). MinION reads were
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Figure 5. Sequencing, assembly and annotation pipeline for plasmid pEG1-1.
Figure 5. Sequencing, assembly and annotation pipeline for plasmid p1-1.

processed using Nanocorrect (Loman et al., 2015) to increase the quality of the lowquality reads produced in the MinION sequence runs (Figure 4). Nanocorrect was
designed to increase the quality of MinION reads through the use of a multiple alignment
process and the raw signal traces produced during the sequence run (Loman et al., 2015).
Loman et al. showed that Nanocorrected MinION reads increased the accuracy of a de
novo assembly from 80.5% to 95.9% (Loman et al., 2015)
SPAdes, a de Bruijin-graph based assembler that constructs contigs (a continuous
sequence constructed by overlapping reads) by merging assemblies based on multiple kmer (substring of length k) sizes (Bankevich et al., 2012), was used to assemble the
normalized PGM reads and Nanocorrected MinION reads into a single 74,212 bp contig
(Figure 5). A 982 bp sequence was repeated on both ends of the contig, suggesting that a
circular genome could be assembled. This region was removed from one end of the
assembly, resulting in a final 73,230 bp contig.
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Accurate de novo assemblies of bacterial genomes can be generated with a depthof-coverage as low as 50X (Desai et al., 2013), and the quality of SPAdes assemblies has
been shown to drop with a depth-of-coverage over 700X (Lonardi et al., 2015). For these
reasons, an acceptable depth-of-coverage range between 50X and 700X was established.
Depth-of-coverage of the assembly was determined by mapping all input data to the
generated contig. The average depth-of-coverage was found to be 287X. Two regions
(549 bp and 33 bp in length) had a depth-of-coverage <50X and no area exceeded 700X.
A BLASTn search (Altschul et al., 1997) of the entire pEG1-1 contig against the
NCBI nucleotide collection database (accessible at:
http://www.ncbi.nlm.nih.gov/nuccore) showed that our assembly matched most closely to
plasmid pB8, a multi-drug resistance plasmid within the Incp-1β incompatibility group
(Schlüter et al., 2005). IncP-1β plasmids have genomes that consist of a conserved
backbone region, interspersed with variable regions – collectively known as the
“accessory region” of the plasmid – that often contain genetic elements such as
transposons and integrons (Popowska & Kraqczyk-Balska, 2013). Mauve (Darling et al.,
2010) was used to perform a global alignment between pB8 and the pEG1-1 assembly.
The alignment revealed four homologous regions that completely encompass the
conserved, backbone region of pB8 (Figure 6.)
When considering only the backbone region , pB8 and pEG1-1 align with
>99.99% identity; only one 24 bp region of the pb8 backbone was not identical to the
pEG1-1 assembly. The high degree of similarity between the conserved backbone of pB8
and the pEG1-1 assembly support the validity of the assembly. The accessory regions of
pB8 have some similarity with the pEG1-1 assembly, but most was dissimilar. This was
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Figure 6. Global alignment of the pEG1-1 assembly and pB8. The pairs of colored boxes
indicate homologous regions between the pEG1-1 assembly (top) and pB8 reference genome
(bottom). A similarity profile that is inversely proportional to the average alignment entropy
over a region of the alignment is drawn within each box. The backbone regions of pB8 have
been marked at the bottom of the figure. An asterisk has been placed at the single dissimilar
region of 24 bp between the pB8 backbone and the pEG1-1 assembly.

not believed to be an indication of error, rather that pEG1-1 carries an accessory load that
differs from pB8.
Annotation. The pEG1-1 assembly was annotated using Prokka, an automated
annotation software that generates gene annotations rapidly by predicting coding regions,
translating those regions into an amino acid sequence, and comparing the amino acid
sequence to databases of known proteins using BLASTp (Seemann, 2014). Predicted
coding regions that match to a known protein with an e-value <10-6 are annotated as the
matched reference. If no match is found to a predicted coding region, it is annotated as a
“hypothetical protein”. Each annotation generated by Prokka was manually inspected to
confirm its validity based on %ID to the matched reference, e-value, and presence of
ribosomal binding sites. The homologous regions of pB8 were also a large factor in the
manual annotation process of the plasmid pEG1-1 backbone. In total, 78 gene annotations
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were made on the pEG1-1 assembly, of which 6 remained “hypothetical proteins” after
both automated and manual annotation (Table 2).

Table 2. Complete list of pEG1-1 genes.
Genea
Accessory Module 1
merR
hypothetical protein
hypothetical protein
strB
repA
mazF
mazE
hypothetical protein
neo
hypothetical protein
hypothetical protein
tetC
teteA
Tnp IS200
tnpA
Initiaiton Module
trfA
ssb
Tra1 Module
trbA
trbB
trbC
trbD
trbE
trbF
trbG

Predicted Function

Startb

Stopb

Strand

involved in mercury resistance
unkown
unkown
aminoglycoside resistance
IncU plasmid replicase
toxin/antitoxin system
toxin/antitoxin system
Uunknown
aminoglycoside resistance
unknown
unknown
tetracycline resistance
tetracycline resistance
transposase
transposase

363
627
1152
2320
3005
3851
4174
5182
7199
8698
8952
9136
10419
11077
13091

512
1049
2114
2949
3499
4174
4398
5934
8014
8889
9080
10326
11054
11412
14311

R
R
F
R
R
R
R
F
F
R
F
R
F
R
F

IncP-1β replication
IncP-1_ replication

14934
16201

16154
16542

R
R

IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer

16656
17328
18307
18775
19083
21638
22417

17018
18290
18771
19086
21641
22420
23337

F
F
F
F
F
F
F
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Table 2. Continued.
Genea
trbH
virB10
trbJ
trbK
trbL
trbM
trbN
trbO
trbP
upf30.5
upf31.0
Accessory Module 2
intl1
aadA
qacEdelta1
sul1
floR
tetR
tetA
gltC
Tnp
groEL/inl1
pse4
aadA
qacEdelta1
sul1
hypothetical protein
tniB
tniA
Tra2 Module
traC
traD
traE
traF
traG
traI
traJ
traK

Predicted Function
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer
IncP-1β transfer

Startb
23340
23833
25254
26028
26266
28002
28603
29267
29533
30247
30833

Stopb
23828
25233
26018
26255
27984
28589
29238
29533
30231
30678
31507

Strand
F
F
F
F
F
F
F
F
F
F
F

Integrase
Aminoglycoside resistance
Integron/antiseptic resistance
Sulfonamide resistance
Florfenicol resistance
Tetracycline resistance
Tetracycline resistance
Transposase
Putative transposase
Integrase fusion protein
Betalactamase
Aminoglycoside resistance
Integron/antiseptic resistance
Sulfonamide resistance
Unknown
Transposase
Transposase

31754
33225
34228
34569
35757
37178
37908
39173
39987
41746
42557
43571
44544
44885
45852
46321
47316

32767
34064
34575
35540
36971
37804
39083
39895
41519
42399
43471
44380
44891
45724
46352
47313
48995

R
F
F
F
F
R
F
F
R
R
F
F
F
F
F
R
R

Type IV secretion system
Type IV secretion system
Type IV secretion system
Type IV secretion system
Type IV secretion system
Type IV secretion system
Type IV secretion system
Type IV secretion system

49546
53895
54306
56381
56914
58824
61099
61847

53891
54284
56369
56917
58827
61064
61473
62245

R
R
R
R
R
R
R
F
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Table 2. Continued.
Genea
traL
traM
Regulation/Stability
Module
kfrC
kfrB
kfrA
korB
incC2
korA
kleF
kleE
kleB
kleA
korC
klcB
klcA
kluA
kluB

Predicted Function
IncP-1_ type IV secretion
system
IncP-1_ type IV secretion
system

Startb

Stopb

Strand

62245

62970

F

62970

63410

F

IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability
IncP-1_ regulation & stability

63613
64295
64813
66024
67070
67831
68247
68779
69253
69527
69923
70197
71454
72051
72699

64266
64642
65844
67073
67834
68133
68777
69108
69468
69763
70180
71402
71882
72320
72990

R
R
R
R
R
R
R
R
R
R
R
R
R
F
F

a

Listed according to distance from oriV on the forward strand.
Base pair position from oriV.

b

pEG1-1 Resistance Phenotype. A modified Stokes disc diffusion antibiotic
susceptibility assay was used by Gehr to determine that plasmid pEG1-1 conferred
decreased susceptibility to tetracycline, kanamycin, piperacillin, ticarcillin, tobramycin,
piperacillin/tazobactam, and cefepime (Gehr, 2013). This resistance profile was
confirmed in the present study. Minimum inhibitory concentrations (MICs) of 22
antibiotics—including ticaracilin, tobramycin, piperacillin/tazobactam, and cefepime—
were determined for pEG1-1. Clinical levels of antibiotic resistance, as defined by
NCCLS standards for Enterobacteriaceae, to ticarcillin and tobramycin were found: MICs
of 4µg/mL and 64µg/mL, respectively. Clinical levels of resistance to the other
antibiotics tested, including piperacillin/taxobactam and cefepime were not observed:
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2µg/mL for doxycycline and no growth observed on the MIC plate in the presence of all
other antibiotics.
Functional Modules of pEG1-1. The 78 genes found on pEG1-1 were classified
into seven functional modules based on the cellular interactions of the encoded proteins
(Figure 7). The initiation module was made up of two genes as well as the origin of
vegetative replication (oriV). The module designated “regulation/stability”, was
comprised of 15 genes encoding proteins with predicted functions involved in
maintenance, partitioning, and plasmid control. The Regulation/Stability and Initiation
modules are separated by Accessory Module 1, a functional module comprised of a
single, large Tn21-related transposon. Genes encoding proteins involved in mate-pair
formation and conjugative DNA-transfer are contained within two functional modules,
Tra1 and Tra2. Tra1 consists of 10 genes and Tra2 was made up of 18 genes. The
modules are separated by Accessory Module 2, a functional module comprised of a single
complex integron, in104.
The modules were divided into two categories: the backbone and accessory
regions. The backbone is a conserved set of genes amongst IncP-1β plasmids and consists
of the regulation/stability, Tra1 and Tra2 modules (Schlüter et al., 2005). A comparison
between other IncP-1β plasmids showed that pEG1-1 possesses a complete set of
backbone genes with an organization nearly completely identical to the backbone of pB8
(Schlüter et al., 2005), suggesting pEG1-1 to be a part of the IncP-1β incompatibility
group. This was confirmed using the integrated web tool PlasmidFinder (Carattoli et al,
2014). The accessory region consists of the Accessory Modules 1 and 2.
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Initiation

Figure 7. The seven functional modules mapped along the multi-drug resistance IncP-1β
plasmid pEG1-1 genome. The origin of vegetative replication (oriV) is marked as a black
circle at the top of the circle. The regulation/stability module (green), Tra1 (light blue),
Tra2(dark blue) and replication module (yellow) make up the IncP-1β backbone genes.
Accessory modules 1 & 2 make up the accessory region and are marked in red. The inner
gray plot indicates the average GC% throughout the plasmid with the dotted line
representing 50% GC content—inside the dotted line <50% GC.

Accessory Modules 1 and 2 contain unique mobile genetic elements that are not
observed in any other sequenced IncP-1β plasmid (Schlüter et al., 2007), but have been
observed on plasmid of other incompatibility groups (Douard et al., 2010; Nass et al.,
2013). Dramatic shifts in the average percent GC of these two modules suggest that these
modules may have been recently incorporated into the pEG1-1 genome via
recombination events (Figure 7).
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Accessory Module 1 (AM1) was made up entirely of a 15,054 bp transposon with
structures related to the Tn21 family, a group of transposons associated with the global
A.
dissemination
of antibiotic resistance (Figure 8a) (Liebert et al, 1999). Tn21 transposons

A
Tn21-related transposon (15,054bp)

merR CDS2 CDS3

strB

repA

mazF mazE CDS3 aphA1 CDS4 CDS5 tetA

tetR

IS200

tnpA

IR

B

IR

.

In104 Integron(17,628bp)

intl1

aadA

qacEΔ1 sul1 floR

tetR

tetA

gltC

tnp

groEL/inI1 pse4

aadA qacEΔ1 sul1

CDS

tniB

tniA
IR

IR

Class 1 integron

Class 1 integron
Transposon element

Transposon element

Figure 8. Genetic map of Accessory Modules 1 & 2. (A) The Tn21-related transposon of
AN1. (B) The In104 integron of AM2. The vertical black bars represent inverted repeat
regions (IR). Coding regions are shown by arrows indicating the direction of transcription.
Black arrows represent genes conferring antibiotic resistance, arrows with vertical stripes
represent conserved transposon genes, arrows with diagonal stripes represent conserved
integron genes, and white arrows represent coding sequences with no known function. The
merR gene and repA gene of the AM1 transposon are represented as a dotted and gray arrow,
respectively. The genes comprising the class 1 integrons and transposon elements of the In104
integron are marked at the bottom.

are characterized by the presence of multiple antibiotic resistance genes, a tnpA
transposase, a tnpR relaxase, a mercury resistance (mer) operon and a pair of Tn21specific inverted repeats flanking the transposon (Liebert et al, 1999). A tnpA transposon
and a pair of Tn21 inverted repeats were observed within the AM1 transposon, but it
lacked a tnpR relaxase and full mer operon—only the merR gene of the operon was found
on the AM1 transposon. Also unique was the presence of the repA gene, encoding the
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replicase enzyme of IncU plasmids (Nass et al., 2013). Six genes related to antibiotic
resistance were found on the AM1 transposon: the genes strB and aphA1 confer
resistance to ampicillin and streptomycin, tetC and tetR confer resistance to tetracycline,
and the mazEF toxin-antitoxin system has been associated with decreased susceptibility
to β-lactam antibiotics (Schuster et al., 2015).
Accessory Module 2 (AM2) was made up entirely of a 17,628bp mobile genetic
element classified as an in104 complex integron (Figure 8b). In104 complex integrons
are found within the Salmonella genomic island 1 (SGI1) and contain two class 1
integrons. Also characteristic of in104 complex integrons is the presence of transposase
enzymes and inverted repeats flanking the entire element. All of these characteristics
were observed in the AM2 element, as well as eight antibiotic resistance genes: the two
aada genes confer resistance to aminoglycoside antibiotics such as streptomycin and
spectomycin, the two sul1 genes confer resistance to sulfonamide antibiotics, both tetR
and tetA confer tetracycline resistance, the floR gene confers resistance to
chloramphenicol and florfenicol and the pse4 gene confers resistance to a broad range of
β-lactam antibiotics.
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Discussion
Sequencing, Assembly and Annotation. Genome studies of multi-drug
resistance plasmids can provide critical insight into the reservoir of antibiotic resistance
genes present in stream sediment. Unfortunately, the plasmid miniprep previously
developed in our laboratory produced low-yields of plasmid DNA that were
contaminated with RNA and chromosomal DNA. These factors made this protocol
initially an impractical option to prepare plasmid DNA for sequencing. In this study, we
have shown that Plasmid-Safe™ ATP-Dependent DNase and RNase A enzymes can
successfully remove the RNA and chromosomal DNA contaminants and that the plasmid
miniprep protocol can be scaled up by a factor of 20 to obtain larger quantities of plasmid
DNA. These methods allow one to obtain large quantities of pure plasmid DNA for
sequencing on NGS platforms. In addition, we were able to develop a fragmentation
method using partial restriction digestion to prepare plasmid DNA for MinION
sequencing.
The sequence data obtained from the PGM and MinION were typical of each
platform (Acinas et al., 2005, Wei & Williams, 2015). The PGM reads were short (~200
bp), but had high phred scores indicative of over 99% base-call accuracy (Figure 3). The
MinION reads were long (mean ~1.6 kb and 4 kb for Run 1 and 2, respectively), but had
lower phred scores indicative of only 90% base-call accuracy (Figure 4).
The relatively complex Ion Torrent sequence protocol led to shorter read-lengths
than anticipated and an uneven ISP Density across the sequencing chip used (Figure 3a),
but the reads produced on the MinION were consistent with the DNA preparation
protocols employed (Figure 4a,b). This suggests that the MinION sequencing protocol
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was more reproducible compared to PGM sequencing. This is important to note if this
protocol is to be adjusted for instructional-laboratory purposes. PGM sequencing requires
a number of skillsets not commonly mastered by undergraduate students, such as DNA
size selection via E-Gel® SizeSelect™ Gels (Thermo Fisher, Waltham, MA), precise
dilutions to a picogram scale, making quality assessments through use of qPCR, emulsion
PCR, and more (Ion Torrent, 2014). MinION sequencing, on the other hand, requires
little more than proper pipetting technique (Sequencing kit SQK-005, Oxford Nanopore,
Oxford UK).
Sequencing of multi-drug resistance plasmids can be conducted on the PGM and
MinION using the methods developed in this study. Despite the more difficult protocol,
the PGM run produced over 4 Mbp of data. On the MinION — between both runs —
over 11 Mbp of 2D data were generated.
The assembly generated in this study was validated by both depth-of-coverage
and the percent identity to a reference sequence. Length-summary statistics on contig
sequences, such as the N50 — a weighted median variable — are commonly employed to
asses the quality of a de novo assembly (Earl et al., 2011). Unfortunately, these metrics
are dependent on an assembly that has generated several contigs of various lengths. In
this study, our sequence reads were assembled into a single contig, forcing us to employ
depth-of-coverage and %ID to a reference genome to asses the assembly generated. For
the pEG1-1 genome, these metrics were sufficient to allow us to assess the quality of the
generated assembly, but our approach was dependent on high depth-of-coverage and an
extant, related reference genome. These limitations may mean that this method of
assessing assembly quality is particularly ill-suited for metaplasmidome studies in which
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a mixed sample of multiple plasmids are sequenced and assessed in a single run (Li et al.,
2015). Having multiple plasmids in a single sample may lower the average depth-ofcoverage below 50X and if a novel plasmid is found within the metaplasmidome, we
would not be able to validate the assembly. Instead, this approach is more appropriate for
single-plasmid studies and may even benefit from the addition of plasmid
incompatibility-group identification prior to sequencing so that reference sequences can
be confirmed. However, if the goal is to isolate and assemble novel plasmids, alternative
metrics to assess such an assembly will need to be established.
Accessory regions of plasmid pEG 1-1. The isolation of an IncP-1β plasmid
from an agriculturally-impacted stream sediment sample was consistent with other
studies: IncP-1β plasmids are typical in bacteria isolated from agricultural sites (Bahl,
2009) and their broad-host range makes exogenous capture into an E. coli recipient a
logical outcome. However, the presence of the in104 complex integron within the pEG11 genome was surprising. The in104 integron is a critical component of the Salmonella
genomic island (SGI1), a multi-drug resistance chromosomal element that is largely
responsible for the global dissemination of multiply-antibiotic-resistant Salmonella
enterica serovar Typhimurium, especially the widely-disseminated multiresistance clone
dT104, after which it was named (Levings et al., 2005). All of the resistance genes
associated with SGI1 are contained within the in104 complex integron (Levings et al.,
2005). Most in104 complex integrons—including the one found on pEG101—carry the
antibiotic resistance genes aadA, sul1, floR, tetA/R, and blaP1 and confer pentaresistance
to aminoglycosides, sulfonamides, florifenicols, tetracyclines and β-lactam antibiotics,
but in104 variants, due to insertion and transposition events, can differ in genotype
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(Seibor & Neuwirth, 2013). Unlike typical integrons, which are not mobile elements, the
in104 complex integron contains genes coding for transposase enzymes that allow it to be
transposed into a host’s chromosome or another plasmid (Levings et al., 2005). An in
vitro study of SGI1 demonstrated that the mobilization of SGI1 resistance depended
specifically on the presence of IncA and IncC plasmids (Douard et al., 2010). Douard et
al., explicitly demonstrated that IncP plasmids were unable to mobilize SGI1 resistance
in repeated mating experiments (Douard et al., 2010) yet our analysis of the pEG1-1
genome clearly indicates the presence of the in104 integron.
This discovery suggests that in104 has undergone recent recombination events
that enable mobilization through a broader range of plasmids. The first in104 integron
described contained a tnpA transposase at the 3’end of the element (Boyd et al., 2001),
but the tnpA gene was absent on the in104 integron of pEG1-1. Instead, tniA and tniB
genes were found at the 3’ end of the integron (Figure 8b). This exchange between the
tnpA and tniA transposase enzymes may be what has allowed the newly acquired
mobilization of in104 on an IncP plasmid.
The in104 complex integron also provides insight on what the original bacterial
host of pEG1-1 may have been. The exogenous capture method used to isolate pEG1-1
was limited in that it provides no evidence on the origin of the plasmid (Gehr, 2013).
However, since the in104 complex integron has only been documented in Salmonella
enterica (Boyd et al., 2001) and Proteus mirabilis, this suggests that pEG1-1 may have
originated in one of these two members of the Enterobacteriaceae (Seibor & Neuwirth,
2013).
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Tn21 transposons are one of the most well-studied transposon families, yet the
gene composition and order of genes within the tn21-related transposon of pEG1-1 was
unlike any of the tn21 reference sequences available (Liebert et al, 1999). The unique
arrangement of this tn21-related transposon suggests it may be a derivative of the tn21
family that, similarly to the in104 integron found on pEG1-1, has undergone a number of
recombination events. For example, the presence of the repA gene suggest that this
transposon may have interacted with the backbone of a different plasmid. Other IncP-1β
plasmids use the replicase enzyme encoded by the trfA gene and do not contain the repA
gene within their backbone (Popowska & Kraqczyk-Balska, 2013). The repA gene on
pEG1-1 may have originated from the backbone of an IncU plasmid, another plasmid
incompatibility group associated with the dissemination of antibiotic resistance that relies
on the repA gene for replication (Cattoir et al., 2008).
The mazEF gene was another distinguishing feature that is not characteristic of
Tn21 transposons. This was a particularly interesting feature since, as described above,
the mazEF toxin-antitoxin (TA) system is attributed to decreased susceptibility to βlactam antibiotics (Schlüter et al., 2015). Additionally, TA systems are involved in
plasmid-addiction systems (PAS), a phenomenon in which successful bacteria
propagation is influenced by the vertical transmission of a plasmid (Van Melderen & De
Bast, 2009). If a bacterium carries a plasmid with a TA system, both the toxin and
antitoxin are passed on to daughter cells. However, if the plasmid is not also replicated
and passed onto the daughter cell, the unstable antitoxin degrades and the stable toxin
persists, killing the daughter cell. Thus the vertical transfer of the plasmid with the
complete TA system is selected for. The mazEF TA system found on pEG1-1 may induce
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a plasmid-addiction system that acts as a major contributing factor to the persistence of
multi-drug resistance plasmids in stream sediment.
The antibiotic resistance profile of pEG1-1 can be attributed to the antibiotic
resistance genes within the AM1 and AM2 modules. Resistance to tetracycline was most
likely conferred by the multiple tetA/R complexes, kanamycin & tobramycin resistance
may be conferred by the aada, strB, or aphA1 genes, and resistance to ticarcillin and
piperacillin was most likely conferred by the pse4 gene. The observed decreased
susceptibility – though not reaching clinical levels of resistance as judged by MICs – to
piperacillin/tazobactam, and cefepime conferred by pEG1-1 may be explained by the
presence of the mazEF TA system. In Staphylococcus aureus, the mazEF TA system is
upregulated under stress conditions and is associated with the formation of small colony
variants and persisters that reside in a drug-tolerant state (Schuster et al., 2015). Schuster
et al. demonstrated that mutations of the S. aureus mazEF TA system led to increased βlactam susceptibility (Schuster et al., 2015) but to this author’s knowledge, the mazEF
TA has not been directly associated with clinical levels of β-lactam resistance,
particularly in Gram-negative bacteria. The presence of genes associated with resistance
to sulfonamide and florfenicol drugs suggest that pEG1-1 may also confer resistance to
additional antibiotics that we have not yet assessed.
Conclusion. The pEG1-1 genome demonstrates how genes conferring heavy
metal resistance, agricultural antibiotic resistance, and human antibiotic resistance can be
linked. This may be concerning for public health since current efforts to mitigate the
emergence of antibiotic resistance focus heavily on the regulation of human antibiotics in
agriculture (The White House Office of the Press Secretary, 2015). However, even in the
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absence of direct selection, clinical antibiotic resistance may be spreading as a
consequence of coselection in response to three different factors: agricultural antibiotic
use—such as tetracycline—heavy metals in the soil—such as mercury—and the plasmid
addiction phenomenon perpetuated by the mazE/F TA system.
Additionally, the presence of the in104 complex integron and the Tn21-related
transposon suggests that multi-drug resistance plasmids are not only capable of
transmission between mature bacteria within stream sediment, but are also actively
recombining. Thus, the increased incidence and new combinations of antibiotic resistance
genes observed in clinical isolates may be only the tip of the vast “iceberg” of resistance
genes actually found in populations of bacteria – and particularly their plasmids – found
in natural environments.
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